Product analysis
Hawthorn Extract offers a focused, reasonably priced hawthorn supplement aimed at heart support. Its generic extract cannot be assumed to reproduce results from the particular preparations used in clinical settings.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
A hawthorn marker is named, but the preparation quality remains uncertain. That description does not establish equivalence to the particular clinical extracts.
Ingredient Transparency100
The ingredient amount and named hawthorn marker are disclosed. That allows a basic label comparison without resolving whether different extracts match.
Value For Money80
Hawthorn offers favorable value at the serving level. Its serving cost makes it a reasonably economical focused extract.
Customer Satisfaction73
Customer feedback is very positive. The very small review pool gives a narrow picture of how widely that satisfaction is shared.
Product Focus73
The intended focus is heart and vascular support, with mixed findings from specific clinical preparations. The generic extract does not establish the same effects or routine prevention of cardiovascular events.
- Format
Capsule - Container
- 120 Capsule(s)
- Per serving
- $0.35
- Customer rating
- 4.9 · 21 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Hawthorn (Crataegus spp.) extract (Vitexins) | 500 mg |
How this ingredient is rated
Composition and Label Disclosure71
Marker and Preparation Disclosure
Species Name Disclosure
Composition and Label Disclosure
Commercial Price and Usability80
Commercial Price per Labeled Serving
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Real world effectiveness of Hawthorn special extract WS 1442 in a retrospective cohort study from Germany.
- Hawthorn (Crataegus spp.) Clinically Significantly Reduces Blood Pressure in Hypertension: A Meta-Analysis of Randomized Placebo-Controlled Clinical Trials.
- A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
- [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
- Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
- [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
- Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
- Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
- Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure--a pooled analysis of clinical trials.